# Healthcare Realty Trust Inc: financial statements, quarterly

HR · NYSE · CIK 1360604 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hr.md) · [Financials](/companies/hr/financials.md) · [Filings](/companies/hr/filings.md) · [Insiders](/companies/hr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.9 d](/filings/0001360604-26-000018.md) | [4.2](/filings/0001360604-25-000059.md) | [4.3](/filings/0001360604-25-000096.md) | [5.0](/filings/0001360604-25-000112.md) | [5.6 d](/filings/0001360604-26-000018.md) | [6.4](/filings/0001360604-26-000042.md) | [7.0](/filings/0001360604-26-000064.md) | [6.9](/filings/0001360604-26-000070.md) | [8.0 d](/filings/0001360604-26-000018.md) | [7.7](/filings/0001360604-26-000042.md) | [8.0](/filings/0001360604-26-000064.md) | [7.9](/filings/0001360604-26-000070.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [63.2 d](/filings/0001360604-24-000026.md) | [61.1](/filings/0001360604-24-000045.md) | [62.5](/filings/0001360604-25-000096.md) | [60.6](/filings/0001360604-25-000112.md) | [58.3 d](/filings/0001360604-26-000018.md) | [54.8](/filings/0001360604-26-000042.md) | [53.3](/filings/0001360604-26-000064.md) | [52.6](/filings/0001360604-26-000070.md) | [48.2 d](/filings/0001360604-26-000018.md) | [43.9](/filings/0001360604-26-000042.md) | [45.1](/filings/0001360604-26-000064.md) | [44.8](/filings/0001360604-26-000070.md) |
| Net income | $m | [(40.5) d](/filings/0001360604-26-000018.md) | [(311)](/filings/0001360604-25-000059.md) | [(144)](/filings/0001360604-25-000096.md) | [(93.0)](/filings/0001360604-25-000112.md) | [(107) d](/filings/0001360604-26-000018.md) | [(44.9)](/filings/0001360604-26-000042.md) | [(158)](/filings/0001360604-26-000064.md) | [(57.7)](/filings/0001360604-26-000070.md) | [14.4 d](/filings/0001360604-26-000018.md) | [(0.1)](/filings/0001360604-26-000042.md) | [(43.5)](/filings/0001360604-26-000064.md) | [(15.8)](/filings/0001360604-26-000070.md) |
| Diluted EPS | $ per share | not reported | [(0.82)](/filings/0001360604-25-000059.md) | [(0.39)](/filings/0001360604-25-000096.md) | [(0.26)](/filings/0001360604-25-000112.md) | not reported | [(0.13)](/filings/0001360604-26-000042.md) | [(0.45)](/filings/0001360604-26-000064.md) | [(0.17)](/filings/0001360604-26-000070.md) | not reported | [0.00](/filings/0001360604-26-000042.md) | [(0.13)](/filings/0001360604-26-000064.md) | [(0.05)](/filings/0001360604-26-000070.md) |
| Basic EPS | $ per share | not reported | [(0.82)](/filings/0001360604-25-000059.md) | [(0.39)](/filings/0001360604-25-000096.md) | [(0.26)](/filings/0001360604-25-000112.md) | not reported | [(0.13)](/filings/0001360604-26-000042.md) | [(0.45)](/filings/0001360604-26-000064.md) | [(0.17)](/filings/0001360604-26-000070.md) | not reported | [0.00](/filings/0001360604-26-000042.md) | [(0.13)](/filings/0001360604-26-000064.md) | [(0.05)](/filings/0001360604-26-000070.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001360604-25-000032.md) | [0.0](/filings/0001360604-24-000045.md) | [0.0](/filings/0001360604-24-000093.md) | [0.0](/filings/0001360604-24-000129.md) | [0.1](/filings/0001360604-26-000018.md) | [0.0](/filings/0001360604-25-000059.md) | [0.0](/filings/0001360604-25-000096.md) | [0.0](/filings/0001360604-25-000112.md) | [0.0](/filings/0001360604-26-000070.md) | [0.0](/filings/0001360604-26-000042.md) | [0.0](/filings/0001360604-26-000064.md) | [0.0](/filings/0001360604-26-000070.md) |
| Total assets | $bn | [12.6](/filings/0001360604-25-000032.md) | [12.3](/filings/0001360604-24-000045.md) | [11.8](/filings/0001360604-24-000093.md) | [11.2](/filings/0001360604-24-000129.md) | [10.7](/filings/0001360604-26-000018.md) | [10.5](/filings/0001360604-25-000059.md) | [10.2](/filings/0001360604-25-000096.md) | [9.9](/filings/0001360604-25-000112.md) | [9.2](/filings/0001360604-26-000070.md) | [9.1](/filings/0001360604-26-000042.md) | [9.0](/filings/0001360604-26-000064.md) | [9.0](/filings/0001360604-26-000070.md) |
| Total liabilities | $bn | [5.7](/filings/0001360604-25-000032.md) | [5.8](/filings/0001360604-24-000045.md) | [5.8](/filings/0001360604-24-000093.md) | [5.6](/filings/0001360604-24-000129.md) | [5.3](/filings/0001360604-26-000018.md) | [5.3](/filings/0001360604-25-000059.md) | [5.4](/filings/0001360604-25-000096.md) | [5.1](/filings/0001360604-25-000112.md) | [4.5](/filings/0001360604-26-000070.md) | [4.7](/filings/0001360604-26-000042.md) | [4.7](/filings/0001360604-26-000064.md) | [4.8](/filings/0001360604-26-000070.md) |
| Long-term debt | $bn | [5.0](/filings/0001360604-25-000032.md) | [5.1](/filings/0001360604-24-000045.md) | [5.1](/filings/0001360604-24-000093.md) | [5.0](/filings/0001360604-24-000129.md) | [4.7](/filings/0001360604-26-000018.md) | [4.7](/filings/0001360604-25-000059.md) | [4.7](/filings/0001360604-25-000096.md) | [4.5](/filings/0001360604-25-000112.md) | [3.9](/filings/0001360604-26-000070.md) | [4.1](/filings/0001360604-26-000042.md) | [4.2](/filings/0001360604-26-000064.md) | [4.2](/filings/0001360604-26-000070.md) |
| Shareholders' equity | $bn | [6.8](/filings/0001360604-25-000032.md) | [6.4](/filings/0001360604-24-000045.md) | [5.9](/filings/0001360604-24-000093.md) | [5.5](/filings/0001360604-24-000129.md) | [5.2](/filings/0001360604-26-000018.md) | [5.1](/filings/0001360604-25-000059.md) | [4.8](/filings/0001360604-25-000096.md) | [4.7](/filings/0001360604-25-000112.md) | [4.6](/filings/0001360604-26-000070.md) | [4.4](/filings/0001360604-26-000042.md) | [4.2](/filings/0001360604-26-000064.md) | [4.1](/filings/0001360604-26-000070.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [127 d](/filings/0001360604-26-000018.md) | [76.2](/filings/0001360604-25-000059.md) | [168 d](/filings/0001360604-25-000096.md) | [119 d](/filings/0001360604-25-000112.md) | [138 d](/filings/0001360604-26-000018.md) | [47.8](/filings/0001360604-26-000042.md) | [163 d](/filings/0001360604-26-000064.md) | [114 d](/filings/0001360604-26-000070.md) | [132 d](/filings/0001360604-26-000018.md) | [52.9](/filings/0001360604-26-000042.md) | [142 d](/filings/0001360604-26-000064.md) | [122 d](/filings/0001360604-26-000070.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [118 d](/filings/0001360604-26-000018.md) | [118](/filings/0001360604-25-000059.md) | [117 d](/filings/0001360604-25-000096.md) | [112 d](/filings/0001360604-25-000112.md) | [110 d](/filings/0001360604-26-000018.md) | [109](/filings/0001360604-26-000042.md) | [109 d](/filings/0001360604-26-000064.md) | [84.8 d](/filings/0001360604-26-000070.md) | [84.4 d](/filings/0001360604-26-000018.md) | [83.9](/filings/0001360604-26-000042.md) | [82.2 d](/filings/0001360604-26-000064.md) | [82.3 d](/filings/0001360604-26-000070.md) |
| Share repurchases | $m | [0.5 d](/filings/0001360604-26-000018.md) | [0.3](/filings/0001360604-25-000059.md) | [0.0 d](/filings/0001360604-25-000096.md) | [0.0 d](/filings/0001360604-25-000112.md) | [8.6 d](/filings/0001360604-26-000018.md) | [0.2](/filings/0001360604-26-000042.md) | [0.5 d](/filings/0001360604-26-000064.md) | [2.9 d](/filings/0001360604-26-000070.md) | [0.4 d](/filings/0001360604-26-000018.md) | [2.0](/filings/0001360604-26-000042.md) | [0.7 d](/filings/0001360604-26-000064.md) | [0.0 d](/filings/0001360604-26-000070.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [379](/filings/0001360604-24-000045.md) | [379](/filings/0001360604-24-000093.md) | [379](/filings/0001360604-24-000129.md) | [379](/filings/0001360604-25-000059.md) | [372](/filings/0001360604-25-000096.md) | [359](/filings/0001360604-25-000112.md) | [350](/filings/0001360604-26-000042.md) | [350](/filings/0001360604-26-000064.md) | [350](/filings/0001360604-26-000070.md) | [347](/filings/0001360604-26-000042.md) | [342](/filings/0001360604-26-000064.md) | [341](/filings/0001360604-26-000070.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 338,539,907 at 2026-10-26, from the cover of the [10-Q filed 2026-10-29](/filings/0001360604-26-000070.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:10 ET. No prices; not investment advice.